CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 146 filers reported holding CLOVIS ONCOLOGY INC in Q4 2014. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $38,529,000 | -10.6% | 418,980 | -14.6% | 0.24% | +3.0% |
| Q2 2015 | $43,112,000 | +16.9% | 490,575 | -1.3% | 0.24% | +18.1% |
| Q1 2015 | $36,886,000 | +34.5% | 496,920 | +1.5% | 0.20% | +30.9% |
| Q4 2014 | $27,419,000 | +30.0% | 489,620 | +5.3% | 0.15% | +26.7% |
| Q3 2014 | $21,084,000 | +20.6% | 464,820 | +10.1% | 0.12% | +27.7% |
| Q2 2014 | $17,480,000 | -41.3% | 422,110 | -1.8% | 0.09% | -39.7% |
| Q1 2014 | $29,762,000 | +53.3% | 429,650 | +33.3% | 0.16% | +59.2% |
| Q4 2013 | $19,419,000 | -12.3% | 322,200 | -11.5% | 0.10% | -21.0% |
| Q3 2013 | $22,137,000 | +2.6% | 364,100 | +13.0% | 0.12% | -6.8% |
| Q2 2013 | $21,584,000 | – | 322,250 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |